Filing Details

Accession Number:
0001522767-23-000111
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-30 17:24:42
Reporting Period:
2023-10-27
Accepted Time:
2023-10-30 17:24:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1522767 Marimed Inc. MRMD Medicinal Chemicals & Botanical Products (2833) 274672745
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789645 R Jon Levine C/O Marimed Inc.
10 Oceana Way
Norwood, MA 02062
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-27 138,889 $0.00 20,240,472 No 4 M Direct
Common Stock Disposition 2023-10-27 41,590 $0.32 20,198,882 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.001 Per Share Restricted Stock Units (RSU) Disposition 2023-10-27 138,889 $0.00 138,889 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
555,555 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,684,640 Indirect By the Jon Levine Family Trust
Footnotes
  1. RSUs convert to shares of common stock on a one-for-one basis.
  2. Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person prior to February 27, 2023 to satisfy tax withholding obligations in connection with the vesting of RSUs.
  3. These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  4. The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.